Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELLMAN, KRISTINA M | 1 | 65.5% | +55.1% |
| SWIFT, CANDICE LEE | 1 | 57.4% | +36.7% |
| ALLEN, MICHAEL D | 1 | 32.4% | +49.2% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| TRAN, CHRISTINA L | 1 | 48.2% | +45.5% |
| REYNOLDS, FRED H | 1 | 33.1% | +39.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17634034 | Hydrophobic Peptide Salts for Extended Release Compositions | REYNOLDS, FRED H | 334d overdue |
| 18273430 | AAV PRODUCTION SYSTEMS FOR AAV VIRAL PARTICLES WITH IMPROVED INFECTIVITY | ALLEN, MICHAEL D | 22d overdue |
| 18573298 | COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF | SWIFT, CANDICE LEE | 4d overdue |
| 18311789 | METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY | MEYERING, SHABANA SHABBEER | 26d |
| 18785340 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | HELLMAN, KRISTINA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17634034 | Hydrophobic Peptide Salts for Extended Release Compositions | REYNOLDS, FRED H | 334d overdue |
| 18273430 | AAV PRODUCTION SYSTEMS FOR AAV VIRAL PARTICLES WITH IMPROVED INFECTIVITY | ALLEN, MICHAEL D | 22d overdue |
| 18573298 | COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF | SWIFT, CANDICE LEE | 4d overdue |
| 18311789 | METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY | MEYERING, SHABANA SHABBEER | 26d |
| 18785340 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | HELLMAN, KRISTINA M | — |
| 18192480 | DYSTROPHIN EXON SKIPPING OLIGONUCLEOTIDES | TRAN, CHRISTINA L | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1657 | 1 |
| 1671 | 1 |
| 1635 | 1 |
| 1637 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18785340 | Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia | HELLMAN, KRISTINA M | 1654 | §101§102§103§112Other | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18573298 | COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF | SWIFT, CANDICE LEE | 1657 | §103§112 | Non-Final OA | 4d overdue | Pending | Dec 21, 2023 |
| 18273430 | AAV PRODUCTION SYSTEMS FOR AAV VIRAL PARTICLES WITH IMPROVED INFECTIVITY | ALLEN, MICHAEL D | 1671 | §102§103§112 | Non-Final OA | 22d overdue | Pending | Jul 20, 2023 |
| 18311789 | METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112Other | Non-Final OA | 26d | Pending | May 03, 2023 |
| 18192480 | DYSTROPHIN EXON SKIPPING OLIGONUCLEOTIDES | TRAN, CHRISTINA L | 1637 | §103DP | Final Rejection | — | Pending | Mar 29, 2023 |
| 17634034 | Hydrophobic Peptide Salts for Extended Release Compositions | REYNOLDS, FRED H | 1658 | §101§102§103§112Other | Non-Final OA | 334d overdue | Pending | Feb 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial